Therefore, we can hypothesise that the cellular components needed for upregulation of GADD34 by cisplatin are present in malignant mesothelioma and head/neck squamous carcinoma cell lines but may not be present in bladder TCC cells. The gene discussed is PPP1R15A; the disease is malignant mesothelioma.